BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 26675309)

  • 1. Flavones inhibit breast cancer proliferation through the Akt/FOXO3a signaling pathway.
    Lin CH; Chang CY; Lee KR; Lin HJ; Chen TH; Wan L
    BMC Cancer; 2015 Dec; 15():958. PubMed ID: 26675309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway.
    Shukla S; Bhaskaran N; Babcook MA; Fu P; Maclennan GT; Gupta S
    Carcinogenesis; 2014 Feb; 35(2):452-60. PubMed ID: 24067903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The flavones apigenin and luteolin induce FOXO1 translocation but inhibit gluconeogenic and lipogenic gene expression in human cells.
    Bumke-Vogt C; Osterhoff MA; Borchert A; Guzman-Perez V; Sarem Z; Birkenfeld AL; Bähr V; Pfeiffer AF
    PLoS One; 2014; 9(8):e104321. PubMed ID: 25136826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flavones inhibit the proliferation of human tumor cancer cell lines by inducing apoptosis.
    Kilani-Jaziri S; Frachet V; Bhouri W; Ghedira K; Chekir-Ghedira L; Ronot X
    Drug Chem Toxicol; 2012 Jan; 35(1):1-10. PubMed ID: 21777131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forkhead Box Transcription Factor (FOXO3a) mediates the cytotoxic effect of vernodalin in vitro and inhibits the breast tumor growth in vivo.
    Ananda Sadagopan SK; Mohebali N; Looi CY; Hasanpourghadi M; Pandurangan AK; Arya A; Karimian H; Mustafa MR
    J Exp Clin Cancer Res; 2015 Dec; 34():147. PubMed ID: 26643256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eugenol-Induced Autophagy and Apoptosis in Breast Cancer Cells via PI3K/AKT/FOXO3a Pathway Inhibition.
    Abdullah ML; Al-Shabanah O; Hassan ZK; Hafez MM
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt.
    Sunters A; Madureira PA; Pomeranz KM; Aubert M; Brosens JJ; Cook SJ; Burgering BM; Coombes RC; Lam EW
    Cancer Res; 2006 Jan; 66(1):212-20. PubMed ID: 16397234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purified vitexin compound 1 induces apoptosis through activation of FOXO3a in hepatocellular carcinoma.
    Wang JG; Zheng XX; Zeng GY; Zhou YJ; Yuan H
    Oncol Rep; 2014 Jan; 31(1):488-96. PubMed ID: 24247909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
    Li A; Wang J; Wu M; Zhang X; Zhang H
    Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell lines.
    Ullmannova V; Popescu NC
    Cancer Detect Prev; 2007; 31(2):110-8. PubMed ID: 17418982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marine lipopeptide Iturin A inhibits Akt mediated GSK3β and FoxO3a signaling and triggers apoptosis in breast cancer.
    Dey G; Bharti R; Dhanarajan G; Das S; Dey KK; Kumar BN; Sen R; Mandal M
    Sci Rep; 2015 May; 5():10316. PubMed ID: 25974307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apigenin, a Partial Antagonist of the Estrogen Receptor (ER), Inhibits ER-Positive Breast Cancer Cell Proliferation through Akt/FOXM1 Signaling.
    Pham TH; Page YL; Percevault F; Ferrière F; Flouriot G; Pakdel F
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of lapatinib and luteolin enhances the therapeutic efficacy of lapatinib on human breast cancer through the FOXO3a/NQO1 pathway.
    Zhang L; Liu Q; Huang L; Yang F; Liu A; Zhang J
    Biochem Biophys Res Commun; 2020 Oct; 531(3):364-371. PubMed ID: 32800546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apigenin induces apoptosis via extrinsic pathway, inducing p53 and inhibiting STAT3 and NFκB signaling in HER2-overexpressing breast cancer cells.
    Seo HS; Choi HS; Kim SR; Choi YK; Woo SM; Shin I; Woo JK; Park SY; Shin YC; Ko SG
    Mol Cell Biochem; 2012 Jul; 366(1-2):319-34. PubMed ID: 22527937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18β-glycyrrhetinic acid induces apoptosis through modulation of Akt/FOXO3a/Bim pathway in human breast cancer MCF-7 cells.
    Sharma G; Kar S; Palit S; Das PK
    J Cell Physiol; 2012 May; 227(5):1923-31. PubMed ID: 21732363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purified vitexin compound 1 inhibits growth and angiogenesis through activation of FOXO3a by inactivation of Akt in hepatocellular carcinoma.
    Wang J; Zheng X; Zeng G; Zhou Y; Yuan H
    Int J Mol Med; 2014 Feb; 33(2):441-8. PubMed ID: 24337611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway.
    Xu Y; Fang R; Shao J; Cai Z
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34036307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equol inhibits proliferation of human gastric carcinoma cells via modulating Akt pathway.
    Yang ZP; Zhao Y; Huang F; Chen J; Yao YH; Li J; Wu XN
    World J Gastroenterol; 2015 Sep; 21(36):10385-99. PubMed ID: 26420965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer.
    Chen J; Gomes AR; Monteiro LJ; Wong SY; Wu LH; Ng TT; Karadedou CT; Millour J; Ip YC; Cheung YN; Sunters A; Chan KY; Lam EW; Khoo US
    PLoS One; 2010 Aug; 5(8):e12293. PubMed ID: 20808831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apigenin suppresses insulin-like growth factor I receptor signaling in human prostate cancer: an in vitro and in vivo study.
    Shukla S; Gupta S
    Mol Carcinog; 2009 Mar; 48(3):243-252. PubMed ID: 18726972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.